Wednesday, March 22nd, 2023

Global Geriatric Medicine Market Industry Overview 2022

Geriatric Medicine Market Industry Overview:

Analysis of global Geriatric Medicine market size by region and country in 2022, as well as current market trends and opportunities for growth in the global Geriatric Medicine market by region and country in 2022. Provide facts and figures. Providers on an individual basis. It also has competitors with basic company introductions and growth rates deduced from historical data.

The examination of the growth of the top market player for the Geriatric Medicine in the target sector covers new projects with SWOT analysis, speculative returns, innovations, and a study of the accessibility of organisations.

Global geriatric medicines market was valued at USD 709,455 million in 2019 and is anticipated to reach USD 1,080,695 million by 2027 at a CAGR of 6% during the forecast period

FREE | Request Sample is Available @

The increased prevalence of chronic conditions such as cardiovascular disease, rheumatoid arthritis, neurological disorders, and cancer are also propelling the market. Geriatrics are more prone to excessive cholesterol, high blood sugar, and inadequate immunity, all of which are contributing to an increase in the occurrence of these disorders. Furthermore, the geriatric population is reliant on polypharmacy, which might result in negative side effects due to drug interactions. As a result, the need for geriatric care has increased, encouraging the growth of the geriatric medications market.

Some of the Top companies Influencing in this Geriatric Medicine Market Overview include:
GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Novartis AG, AstraZeneca plc, Merck & Company Inc., Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., and Sanofi S.A.

About Us: is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.

Contact Us:

825 3rd Avenue, New York, NY, USA, 10022
Tel: +1 6464807505, +44 203 318 2846

Leave a Reply

Your email address will not be published. Required fields are marked *